Related Experiment Video
Updated: Sep 4, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
A Comparative Study on Intranasal Versus Intravenous Lorazepam in the Management of Acute Seizure in Children
Nandan Rudra1, Taraknath Ghosh2, Uttam Kumar Roy3
1Kalna Subdivisional & Superspeciality Hospital, Purba Burdwan (West Bengal), India.
Insights
Intranasal lorazepam is as effective and safe as intravenous lorazepam for treating acute childhood seizures. This study suggests intranasal lorazepam is a viable alternative for emergency seizure management in children.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Pharmacology
- Neurology
Background:
- Acute seizures in children are medical emergencies often treated with benzodiazepines.
- Intravenous lorazepam is a recommended first-line therapy, but intranasal administration lacks established guidelines in India.
- Intranasal lorazepam offers potential advantages in ease of administration and home-based treatment initiation.
Purpose of the Study:
- To compare the effectiveness and safety of intranasal versus intravenous lorazepam for acute seizures in children aged 5-12 years.
- To evaluate intranasal lorazepam as a potential alternative to intravenous administration.
Main Methods:
- An analytical observational cross-sectional study design was employed.
- Patients with acute seizures received lorazepam via either the intravenous or intranasal route.
- The formulation and dosage of lorazepam were consistent across both administration routes.
Main Results:
- No statistically significant differences were observed in patient demographics (sex, age, weight) between the groups.
- Seizure control within 10 minutes and persistent cessation of seizure activity were comparable between intranasal and intravenous lorazepam.
- Safety parameters demonstrated no significant differences between the two administration routes.
Conclusions:
- Intranasal lorazepam demonstrates comparable effectiveness and safety to intravenous lorazepam in managing acute childhood seizures.
- Intranasal lorazepam presents a valuable alternative option for emergency seizure management in pediatric patients.
- Further research may support broader adoption of intranasal lorazepam in clinical practice.
Introduction:
The acute seizure in childhood is a medical emergency which is usually managed by benzodiazepines used as a first line of therapy. There are no strict guidelines of using intranasal lorazepam in India. Many paediatricians use it in an emergency situation as it is inexpensive, easy to administer and even treatment can be started at home. Very few studies are available to compare efficacy and safety of intravenous lorazepam with intranasal lorazepam in childhood seizure, though both routes have comparable pharmacokinetic profile. Intravenous lorazepam (0.1 mg/kg) is already recommended as a first-line treatment of acute childhood seizures in India. There are very few studies regarding the usefulness of intranasal lorazepam. With this background, we compared intranasal lorazepam with the more widely accepted intravenous lorazepam for control of acute seizure.
Aim:
To compare effectiveness and safety of intranasal and intravenous lorazepam in acute seizure in children aged 5-12 years.
Materials And Methods:
This is an analytical observational cross-sectional study involving patients with acute seizure who received lorazepam via either the intravenous or intranasal route. Formulation and dosage of lorazepam were the same in both routes.
Results:
Distributions of patient groups according to sex, age, and weight were statistically not significant (p=0.42, p=0.391, and p=0.605, respectively). Time to control seizure within 10 min and persistent cessation of seizure activity were similar in both groups. Safety parameters showed no differences statistically.
Conclusions:
Though intravenous lorazepam is recommended as first-line treatment, intranasal lorazepam may be a good alternative choice in a convulsing child.
More Related Videos
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...